Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGB for Cerebral Vasospasm Prevention in Aneurysm Surgery
NCT02275247Unknown
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Aug 2014
- Primary completion
- Oct 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine in cerebral vasospasm, sponsored by General Hospital of Ningxia Medical University. Primary endpoint: Incidence of cerebral vasospasm at 7 days. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
cerebral vasospasm
Beyond the preview
Go deeper on NCT02275247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02275247.